GlassScriptPhysician profile
David R Richardson
NPI 1912994450
$60,592.42
in general payments reported to CMS, 2019-2025
12 companies · $5,245 in 2025
The $5,245 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $8,531 · 2021: $11K · 2022: $9,751 · 2023: $8,350 · 2024: $5,734 · 2025: $5,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $19K · Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $18,699.00 |
| Food and Beverage | $630.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $55,768.00 | 2019-2025 | Io Fix, Axis |
| Gentleman Orthopedic Solutions | $3,673.64 | 2019-2025 | |
| Stryker Corporation | $358.95 | 2021-2023 | Easyfuse, Infinity, Inbone |
| Treace Medical Concepts, INC. | $175.53 | 2022-2025 | |
| Crossroads Extremity Systems, LLC | $169.13 | 2019 | |
| Depuy Synthes Sales INC. | $141.29 | 2022 | |
| Sanara Medtech INC. | $92.86 | 2024 | Celleraterx |
| Djo, LLC | $70.40 | 2025 | Cmf |
| Integra Lifesciences Corporation | $55.37 | 2019 | |
| Janssen Pharmaceuticals, INC | $50.80 | 2024-2025 | Spravato |
| Vertex Pharmaceuticals Incorporated | $21.44 | 2025 | |
| Heron Therapeutics, INC. | $15.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.